How Does Elvanse Work? A Clinician's Guide for UK Adults
Most people are handed a prescription with a five-minute explanation and a leaflet. Then they take the first capsule, feel very little for two hours, and start wondering whether it's working.
This page explains what lisdexamfetamine actually does, on what timetable, and why the first few days tell you much less than you'd think.
Written and clinically reviewed by a prescriber. It's information about a prescription-only medicine, not a recommendation to take it — that decision needs an individual assessment.
What it is
Lisdexamfetamine is a prodrug: the molecule in the capsule has no stimulant activity of its own. It's dexamfetamine chemically bonded to lysine, an ordinary amino acid.
That bond has to be broken before anything happens, and it's broken enzymatically in the blood — not in the stomach. This single design decision explains almost everything else about how the medicine behaves.
What it does once it's active
Once the lysine is cleaved off, the freed dexamfetamine increases the availability of two neurotransmitters in the brain: dopamine and noradrenaline.
In ADHD, the networks that handle sustained attention, working memory, motivation and impulse control appear to be under-served by these two. Raising their availability improves signalling in those networks. That's the whole mechanism — it isn't adding anything the brain doesn't have, it's changing how much is available at the synapse.
Which is why the honest description of a good dose is "quieter", not "energised". People often expect stimulation and get stillness instead.
The timetable
This is the part most worth getting right, because expectations set on day one determine whether someone sticks with treatment.
0–1 hour. Very little. Conversion is still underway. If you feel a sharp hit in the first hour, that's worth mentioning to your prescriber rather than treating as the medicine working.
1–3 hours. Levels climbing. Most people notice something in this window — often subtle.
3–4 hours. Peak plasma concentration in adults.
Through the day. A long plateau rather than a peak and a drop. This is the point of the prodrug design.
13–14 hours. Effects were still measurable at 13 hours in children and 14 hours in adults in clinical studies. Individual experience varies considerably.
Why it matters: because the conversion is enzymatic and rate-limited, the rise is gradual whatever you do to the capsule. Opening it and dissolving the contents in water — which is fine to do, and is how some people take it — does not speed it up. Neither does chewing it.
Why the first dose tells you almost nothing
Three reasons, and all three cause people to abandon treatment that would have worked.
The starting dose is a safety dose, not a treatment dose. Titration begins low deliberately. It is not an attempt to find the right dose first time.
The absence of drama is not the absence of effect. The most commonly reported sign of a working dose is that something didn't happen — you didn't lose the thread, didn't open a new tab, didn't leave the task. Negatives are hard to notice in the moment and often easier to spot in hindsight, or from someone who lives with you.
Day-to-day variables are larger than you'd expect. Sleep debt, an empty stomach, illness or a heavy week will all blunt the picture. A fortnight of poor sleep will make an adequate dose look like a failure.
The reliable read comes from a titration run properly over eight to twelve weeks, with objective monitoring at each step — not from week one.
Already diagnosed and taking ADHD medication? Transfer your ADHD care → →
How it differs from the alternatives
The mechanism explains the practical differences, so it's worth putting them side by side.
| Medication | How it gets active | Shape of the day |
|---|---|---|
| Lisdexamfetamine (Elvanse) | Prodrug — converted in the blood, rate-limited by enzymes | Gradual rise, long plateau, gradual fall. Up to ~14 hours in adults |
| Methylphenidate MR (Concerta XL, Medikinet XL) | Active on release; formulation controls the release profile | Depends entirely on the formulation — some are designed with two distinct pulses, so the day has a shape to it |
| Dexamfetamine IR (Amfexa) | Active immediately | Fast on, fast off. 4–6 hours, usually needing a second dose |
| Atomoxetine (Strattera) | Not a stimulant — a noradrenaline reuptake inhibitor | No daily curve at all. Builds over weeks to a steady state |
Curves are illustrative, not to scale.
On which comes first: UK guidance (NICE NG87) generally puts methylphenidate first-line for adults, with lisdexamfetamine where methylphenidate has been tried for an adequate period and hasn't worked well enough or wasn't tolerated. Which is right for a given person is a clinical decision, not a preference.
Who it tends to suit
Not a recommendation, and not a substitute for assessment — but these are the patterns that come up:
People who need coverage across a long day rather than a working morning
People who've found shorter-acting stimulants too abrupt at either end
People who struggle to remember a midday dose — which, given what's being treated, is not a small consideration
People for whom methylphenidate was tried and didn't do enough
And the honest other side: the slow onset frustrates people who want to feel a clear change, and the long tail is a problem if you're sensitive to sleep disruption. Both are dose and timing conversations, not reasons to give up on treatment.
Common side effects
Listed as very common — more than 1 in 10 people — in the UK product information: decreased appetite, difficulty sleeping, dry mouth, headache, upper abdominal pain, weight loss. Increased heart rate and blood pressure are also reported.
Most are most pronounced early and settle for many people. Appetite and sleep are the two that most often drive a dose change.
Anything cardiac — chest pain, breathlessness on exertion, fainting — or a significant change in mood needs to reach your prescriber straight away, not wait for the next review.
What this needs from a prescriber
Lisdexamfetamine is a Schedule 2 controlled drug, licensed for use under specialist supervision as part of a comprehensive treatment programme. In practice that means:
Cardiovascular assessment before the first dose, and monitoring throughout
Blood pressure and pulse rechecked after every dose change
Monthly prescriptions — Schedule 2 rules limit supply to 30 days, and a prescription must be dispensed within 28 days of its date
Someone holding clinical responsibility for as long as you're taking it
That last one is where UK adults most often come unstuck. The medicine works; the prescribing arrangement falls over.
Adult ADHD prescribing
Diagnosed in the UK, but no one is prescribing?
Focus Gently is a CQC-registered remote adult ADHD service. Send us your existing diagnostic report and we'll review it free of charge, then tell you honestly whether we can take over your titration, monitoring and prescriptions.
- Free report review and a free 15-minute call with a prescriber
- £89/month — all reviews and prescriptions included, no joining fee
- Cancel any time; annual shared care request to your GP
A UK diagnosis and a home blood pressure monitor are required. Medication is dispensed and charged separately by our partner pharmacy.
Already diagnosed and looking to start titration?
